Artificial intelligence, automation, and advanced technologies are reshaping how pharmacy leaders manage inventory, optimize workflows, and improve operational performance. From predictive analytics and decision support tools to robotics and automated dispensing technologies, innovative solutions are creating new opportunities to enhance efficiency, reduce manual burden, and strengthen medication safety. In this session, explore real-world applications of emerging technologies and examine how pharmacy leaders are evaluating, implementing, and scaling these capabilities across IDNs.

Join pharmacy supply chain leaders as they share practical use cases, lessons learned, and perspectives on the technologies transforming the future of pharmacy operations.

Learning Objectives:
1. Identify emerging AI, automation, and robotics applications within pharmacy supply chain and operations.
2. Analyze opportunities for technology-enabled improvements in efficiency, inventory management, and workflow optimization.
3. Evaluate the impact of AI and automation on medication safety and operational performance.
4. Assess considerations for implementing and scaling innovative technologies within pharmacy environments.

Pharmacy leaders continue to navigate an increasingly complex environment shaped by reimbursement pressures, medication shortages, fluctuating drug costs, and evolving patient care demands. Successfully managing pharmacy financial performance requires a coordinated approach that integrates revenue cycle management, supply chain resilience, and proactive forecasting. This session takes a deep-dive into strategies for maintaining financial stability while ensuring access to critical therapies, managing disruption, and adapting to ongoing market volatility.

Join pharmacy executives and industry leaders as they discuss practical approaches to strengthening financial performance, improving forecasting accuracy, and building more resilient pharmacy operations.

Learning Objectives:
1. Identify key factors influencing pharmacy revenue cycle performance and financial sustainability.
2. Analyze strategies for mitigating the impact of supply disruptions and drug shortages on pharmacy operations.
3. Evaluate forecasting and budgeting approaches that improve financial visibility and operational planning.
4. Develop strategies for aligning revenue cycle, financial, and supply chain priorities within pharmacy services.

Rising pharmaceutical costs, ongoing market volatility, and increasing pressure on healthcare margins continue to challenge pharmacy leaders across the country. As IDNs seek strategies to manage costs while maintaining access to essential therapies, GPOs play an increasingly important role in contracting, market intelligence, sourcing strategies, and supply assurance. Gain insights into current market conditions, emerging trends, and the approaches being used to help health systems navigate a rapidly changing pharmacy landscape.

Join leaders from each of the National GPOs as they share their outlook on cost pressures, supply challenges, and the opportunities they see for supporting pharmacy performance in the years ahead.

Learning Objectives:
1. Identify key market forces contributing to rising pharmaceutical costs and pricing volatility.
2. Analyze current strategies being utilized to manage cost pressures while maintaining continuity of supply.
3. Evaluate the role of GPO partnerships in supporting contracting, sourcing, and pharmacy performance objectives.
4. Assess emerging trends that may influence pharmacy purchasing, budgeting, and supply chain strategies moving forward.

The 340B Drug Pricing Program remains a critical yet increasingly complex component of pharmacy financial strategy for both covered entities and ineligible entities. Ongoing legal, regulatory, and operational pressures are shaping how all health systems manage budgeting, compliance, eligibility, and program sustainability. As the environment continues to evolve, all pharmacy leaders must balance financial changes in the program with heightened scrutiny, changing manufacturer practices, and increasing administrative complexity. In this session, explore the current state of the 340B landscape and the strategies IDNs are using to protect themselves in this changing environment while also adapting to emerging challenges.

Join a healthcare and legal industry thought leader with expertise in both pharmacy operations and regulatory frameworks as they provide an updated perspective on the future of the 340B program and its implications for IDN pharmacy strategy.

Learning Objectives:
1. Identify current legal, regulatory, and operational trends impacting the 340B program.
2. Analyze risks and challenges associated with maintaining program compliance and financial sustainability.
3. Evaluate strategies health systems are using to adapt to increasing scrutiny and complexity in 340B operations.
4. Assess potential future scenarios for the 340B program and their implications for pharmacy leadership planning.

Pharmacy reimbursement continues to evolve under the pressure of shifting payer dynamics, changing acquisition costs, and increasing complexity in reimbursement models across both inpatient and outpatient settings. For pharmacy leaders, these changes directly impact budgeting accuracy, formulary decisions, and overall financial sustainability. Examine the current state of pharmacy reimbursement, including key trends shaping payment structures, margin variability, and the operational implications for health system pharmacy programs.

Join Bonnie Kirschenbaum as she provides an update on the evolving reimbursement environment and discuss strategies for maintaining financial stability in a highly variable landscape.

Learning Objectives:
1. Identify key trends and shifts influencing pharmacy reimbursement across care settings.
2. Analyze the operational and financial implications of reimbursement variability on pharmacy budgets and decision-making.
3. Evaluate strategies for improving financial forecasting and margin management in response to reimbursement changes.
4. Assess how reimbursement dynamics influence formulary, sourcing, and operational pharmacy decisions.

As pharmacy and supply chain operations become increasingly interconnected, stronger collaboration between these functions is essential to improving patient care, increasing operational efficiency, and delivering greater financial value across the IDN. This session explores how Vanderbilt Health has built an integrated partnership between its separate Pharmacy and Supply Chain teams, highlighting best practices in collaborative governance, sourcing and contracting, vendor management, technology integration, and data-driven decision-making. Gain practical insights into the organizational structures, standardized workflows, and cross-functional strategies that support resilient medication and supply operations while driving measurable enterprise value.

Join pharmacy and supply chain leaders from Vanderbilt Health as they share their approach to aligning clinical, operational, and financial priorities through a successful collaborative pharmacy and supply chain model.

Learning Objectives:
1. Describe the organizational structure of the Pharmacy and Supply Chain teams in an integrated healthcare delivery model
2. Identify Best Practices for collaborative sourcing, contracting, vendor management, and medication/supply procurement
3. Explain how technology, analytics, and standardized workflows improve operational efficiency and financial performance
4. Apply strategies to enhance cross-functional collaboration through cost-savings identification, tracking, and implementation